[1]CurrentPatentAssignee:PFIZERINC-US2012/10183,2012,A1Locationinpatent:Page/Pagecolumn51
[1]CurrentPatentAssignee:FELICITEXTHERAPEUTICS-US2018/179199,2018,A1Locationinpatent:Paragraph0450;0597-0598
16778-21-5
1189107-33-2
5622-06-0
860232-96-8
36748-98-8
1803582-34-4
1309980-29-7 | 2-Methyl-4-trifluoromethoxyphenylboronic acid, pinacol ester | AA009WSF | MFCD11867879
1393442-26-6 | 4-Bromo-N,N-diethyl-2-methoxybenzamide | AA009WWL | MFCD22383681
1420800-37-8 | 3-Bromo-4-(ethylamino)-5-nitrobenzonitrile | AA009X0C | MFCD22689134
127958-62-7 | 5,5-Dimethylmorpholin-3-one | AA009X4A | MFCD10040125
134541-08-5 | 5-(Methoxymethyl)isoxazole-4-carboxylic acid | AA009XBP | MFCD13193540
133546-50-6 | 5,10-DibroMonaphtho[1,2-c | AA009XNZ | MFCD31618129
1331186-01-6 | 1-((4-broMo-2-fluorophenyl)sulfonyl)-4-Methylpiperidine | AA009YDM | MFCD20037344
1427379-23-4 | (2-Bromo-4-chlorophenyl)methanesulfonyl chloride | AA009YP8 | MFCD23144024
1356848-13-9 | N-Acetyl-S-(2-cyanocarboxyethyl)-L-cysteine-d3 Bis(dicyclohexylaMine) Salt | AA009Z2K
1268982-48-4 | [1-(2,4-DIMETHYLPHENYL)PROPYL]AMINE HYDROCHLORIDE | AA009ZQG | MFCD18483414